RxDoctor Payments Data

Tiffany Trent, APRN

Nurse Practitioner · Tampa, FLNPI 1477969582

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Arcutis Biotherapeutics, Inc. accounts for 60.7% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $33,297, more than ten times the $877 reported in 2022. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,519in general payments, 2019–2025

Across 372 payments — averaging $125.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$28K
  • Kowa Pharmaceuticals America, Inc.$7K
  • AbbVie$3K
  • Sun Pharmaceutical Industries Inc.$2K
  • Johnson & Johnson$1K
  • Galderma Laboratories, L.p.$869
  • plus $4K from 21 others

What the payments were for

  • Consulting fees$23,45050%
  • Speaking & faculty fees$6,30014%
  • Travel & lodging$2,9096%
  • Food & beverage$13,78530%
  • Education$750%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,519 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$5,366
Medicare patients
49
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab13$93,356
Dupixent PenDupilumab19$81,723
Clobetasol Propionate117$4,725
Ketoconazole195$2,797
Triamcinolone Acetonide221$2,034
Tretinoin28$1,363
Metronidazole24$1,046
Fluorouracil13$993
Doxycycline Hyclate61$877
ValacyclovirValacyclovir Hcl21$535
Clindamycin Phosphate15$460
Fluocinonide13$445
Mupirocin43$337
Betamethasone Dipropionate18$320
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip19$273

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →